R. Meena, N. Biswas, L. Kumar, T. Velpandian, and Y. Gupta, “Safety Profile of Imatinib in Indian Chronic Myeloid Leukemia Patients”, Health Renaissance, vol. 9, no. 1, pp. 24–30, Mar. 2011.